Duligotuzumab | Interleukin Related interleukin-related.com

Product Name :
Duligotuzumab

Search keywords :
Duligotuzumab

drugId :
null

Target Vo:
Epidermal growth factor receptor erbB1

Target Vo Short Name :
EGFR

Moa_Name:
Epidermal growth factor receptor erbB1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Genentech Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Colorectal Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DLST Antibody
Alexa Fluor® 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L
Histone H3 (mono methyl K18) Antibody: Histone H3 (mono methyl K18) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 15 kDa, targeting to Histone H3 (mono methyl K18). It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts